Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Health Economics & Costs

FDA Finally Approved an OTC Oral Contraceptive; Now it Should Approved Competing Ones

Posted on July 13, 2023 by Devon Herrick

The U.S. Food and Drug Administration has finally approved an over-the-counter hormonal birth control pill.

At a time of unrelenting attacks on reproductive autonomy, the Food and Drug Administration’s decision on July 13 to approve a birth control pill for over-the-counter (OTC) use is an important advance toward providing people with tools to control their fertility. This includes preventing unwanted pregnancy. Having Opill, a safe, effective, easy-to-use birth control option available without a prescription is essential, because it so difficult for many people to get prescription birth control in the U.S.

+

Thursday Links

Posted on July 13, 2023July 12, 2023 by John C. Goodman
  • Generic drug prices are falling. That’s good news for consumers unless the drug is not available.
  • Study: China’s New Cooperative Medical Scheme has saved lives, increased life expectancy.
  • Poland experienced five decades of a planned economy, followed by three decades of market orientation. The market is better.
  • Pre Obamacare, Did Health Insurance Companies Refuse to Insure a Lot of People?
  • Why do so many private schools look just like public schools?
+

Wednesday Links

Posted on July 12, 2023July 12, 2023 by John C. Goodman
  • California considers affirmative action for prison sentences.
  • Arnold Kling against marijuana.
  • “We propose a new priority review voucher program to incentivize competition in limited-competition, small molecule generics markets.”
  • Study: “We estimate that the recently proposed US price controls on drugs in the US would raise health care spending by $50.8 billion over a 20-year period.”
+

Monday Links

Posted on July 10, 2023July 10, 2023 by John C. Goodman
  • British patients are not grateful for the free care they receive from the NHS.
  • Pfizer: antibiotic shortage could worsen syphilis epidemic. (NYT)
  • Should you worry about “forever chemicals” in your drinking water?
  • Turley to Zuckerberg: “Release the Facebook Files.”
  • Evidence lacking that dietary supplements sharpen the mind.
  • Negative results from Portugal’s experiment with decriminalization of drug use.
  • Another article on drug shortages that fails to ask the obvious question: Why isn’t there a shortage of aspirin?
+
  • Previous
  • 1
  • …
  • 245
  • 246
  • 247
  • 248
  • 249
  • 250
  • 251
  • …
  • 368
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom